Denali Therapeutics (NASDAQ:DNLI) Releases Quarterly Earnings Results, Misses Estimates By $0 05 EPS themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Denali Therapeutics (NASDAQ:DNLI – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($0.86) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.81) by ($0.05), Briefing.com reports. Denali Therapeutics had a negative return on equity of 11.54% and a negative net margin of 36.51%. During the same […]
Profund Advisors LLC lowered its stake in Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) by 13.6% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 40,154 shares of the company’s stock after selling 6,321 shares during the quarter. Profund Advisors LLC’s holdings in Denali Therapeutics […]
Denali Therapeutics Inc (NASDAQ:DNLI) Receives Consensus Rating of Buy from Brokerages theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Denali Therapeutics (NASDAQ:DNLI) Receives Buy Rating from HC Wainwright dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.